Variables

Male (N = 48)

Female (N = 50)

Total

X2

p Value

n(%)

N (%)

Age groups (years)

<20

16 (33.3)

8 (16.0)

24 (24.5)

12.869

0.025*

20 - 29

1 (2.1)

9 (18.0)

10 (10.2)

30 - 39

14 (29.2)

20 (40.0)

34 (34.7)

40 - 49

14 (29.2)

8 (16.0)

22 (22.4)

50 - 59

3 (6.2)

4 (8.0)

7 (7.1)

60 - 69

0 (0.0)

1 (2.0)

1 (2.0)

Weight (kg)

<20

8 (16.7)

4 (8.0)

12 (12.2)

14.986

0.036*

20 - 29.9

5 (10.4)

2 (4.0)

7 (7.1)

30 - 39.9

1 (2.1)

3 (6.0)

4 (4.1)

40 - 49.9

5 (10.4)

17 (34.0)

22 (22.4)

50 - 59.9

15 (31.2)

14 (28.0)

29 (29.6)

60 - 69.9

7 (14.6)

9 (18.0)

16 (16.3)

70 - 79.9

6 (12.5)

1 (2.0)

7 (7.1)

999

1 (2.1)

0 (0.0)

1 (1.0)

Residence

Urban

33 (68.8)

28 (56.0)

61 (62.2)

1.694

0.193

Rural

15 (31.2)

22 (44.0)

37 (37.8)

Site of disease

Pulmonary

43 (89.6)

47 (94.0)

90 (91.8)

0.637

0.425

Extrapulmonary

5 (10.4)

3 (6.0)

8 (8.2)

Sputum AFB status

Positive

17 (36.2)

19 (38.0)

36 (37.1)

3.161

0.367

Negative

18 (38.3)

25 (50.0)

43 (44.3)

Unable to produce sputum

10 (21.3)

5 (10.0)

15 (15.5)

Others

2 (4.3)

1 (2.0)

3 (3.1)

Antiretroviral treatment status

On treatment

21 (43.8)

25 (50.0)

46 (46.9)

0.384

0.535

Not on treatment

27 (56.2)

25 (50.0)

52 (53.1)

Treatment Regimen

Category 1

46 (95.8)

48 (96.0)

94 (95.9)

0.002

0.967

Category 2

2 (4.2)

2 (4.0)

4 (4.1)